Akamai Technologies

Image representing Akamai as depicted in Crunc...

Image via CrunchBase

AKAM : NASDAQ : US$46.12
BUY 
Target: US$51.00

COMPANY DESCRIPTION:
Akamai provides content delivery and cloud infrastructure services for accelerating and improving the delivery of content and applications over the Internet, ranging from live and on-demand streaming videos to conventional web content, to c-commerce tools. The company is headquartered in Cambridge, Massachusetts.

Investment recommendation


With strong volume momentum in the underlying business and continued improvements in the company’s cost structure as spelled out in the 10-Q, we increasingly believe Akamai is once again set to deliver impressive results for the balance of the year despite the incremental investments in the business this and next year. Accordingly, we are increasing our estimates and our price target to $51 from $46 on the belief of an upward bias to estimates and the recognition that volume growth might offset the incremental margin pressures associated with investments announced earlier this year.
Investment highlights
 Strong growth likely sustainable – With multiple companies in the sector reporting similar trends, we believe the surprisingly accelerating revenue growth reported by AKAM in Q1/13 is sustainable throughout the year. We believe guidance remains conservative.
 Cost improvements continue – Based upon details reported in the company’s 10-Q, we believe it is likely that key fixed components of the company’s cost structure will continue to improve. Although additional investments are likely in Q2/13, we expect margins could improve starting in 2014.
 AKAM remains a BUY-rated stock – Even though the stock has recovered from the lows of the year, we continue to recommend the shares for purchase. Although volatile, we continue to believe shares represent an attractive risk/reward for investors

Related articles
Leave a Comment
by jackbassteam on May 24, 2013  •  Permalink
Posted in Tech stocks, Telecommunications
Tagged , , , , , , ,

Posted by jackbassteam on May 24, 2013

http://amp2012.com/2013/05/24/akamai-technologies-2/

Stock Market Magic: Building Your Apprentice Millionaire Portfolio 30 % Return Annually

Available from Amazon.com

Close window
Stock Market Magic: Building Your Apprentice Millionaire Portfolio 2012: All you need to succeed in today’s stock market

 

 

 

 

Edit

 

” Only Gold Is Real Money “

Here’s the shirt:

Only Gold is Real Money Tees

Edit

 The Gold Investor’s Handbook “ by Jack A. Bass, B.A. LL.B.

( available from Amazon)

1oz 1984 Krugerrand Transferred from en.wikipedia

1oz 1984 Krugerrand Transferred from en.wikipedia (Photo credit: Wikipedia)

1oz 1984 Krugerrand Transferred from en.wikipedia (Photo credit: Wikipedia)

1oz 1984 Krugerrand Transferred from en.wikipedia (Photo credit: Wikipedia)

Why Invest in Gold and Gold Stocks – and Why Now ?

Historically, gold has been a proven method of preserving value when a national currency was losing value. If your investments are valued in a depreciating currency, allocating a portion to gold assets is similar to a financial insurance policy. In the past year, the climb in the price of gold above $1600 per ounce is due to many factors, one being that the dollar is steadily losing value.

  • The dollar is weak and getting weaker due to national economic policies  like quantitative easing , which don’t appear to have an end.
  • Gold price appreciation makes up for lost interest, especially in a bull market.
  • The last ten years are a major bull move similar to the 70′s when gold moved from $38 to over $800.
  • Central banks in several countries have been increasing their gold holdings as part of their foreign reserves, instead of selling.
  • All gold funds are in a long term uptrend with bullion get  ready for an new gold bull market surge in 2013.
  • The trend of commodity prices  ( such as food stuffs ) to increase is relative to gold price increases.
  • Worldwide gold production is not matching consumption. The price will go up further with demand.
  • Most gold consumption is done in India and China and their demand is increasing with their increase in national wealth.
  • U.S. government economic policies over the past decade have systematically projected the U.S. economy down a road with uncontrollable federal spending and an uncontrollably increasing trade deficits. Both will cause the dollar to lose in international value and will increase the price of alternative investments, such as gold.
Leave a Comment
by jackbassteam on May 24, 2013  •  Permalink
Posted in Amazon, AMP Book
Tagged , , , , , , ,

Posted by jackbassteam on May 24, 2013

http://amp2012.com/2013/05/24/stock-market-magic-building-your-apprentice-millionaire-portfolio-30-return-annually-2/

LinkedIn BUY Target $ 200

Image representing LinkedIn as depicted in Cru...

Image via CrunchBase

LNKD : NASDAQ : US$176.95
BUY 
Target: US$200.00

COMPANY  DESCRIPTION:

LinkedIn is the world’s largest professional network on the Internet with more than 200 million members in over 200 countries and territories. LinkedIn generates revenue through selling Hiring Solutions to corporations, Marketing Solutions to Advertisers, and Premium Subscription to members and recruiters.

Investment recommendation

We areincreasingly confident in the company’s strategy, opportunity, competitive position and long-term outlook. We note greater interest in
the transition occurring within Marketing Solutions and the timing of when growth might reaccelerate, and we will be watching the company’s progress with feed-based Sponsored Updates advertising for signs of inflection later this year.
Investment highlights
 We continue to expect Marketing Solutions (MS) revenue growth to be relatively flat sequentially for Q2 and Q3, as ~$8-10 million per quarter in “legacy” ad revenue rolls out of the model; we believe Sponsored Updates can return MS to growth by Q4.
 Member engagement continues to climb, and our new engagement index shows a doubling of per-member activity over the past five quarters.
 The transition to in-house hosting could contribute to as much as 500 bps of gross margin expansion over the next four years, although we are only modeling 300 bps.
Valuation
Our $200 price target is unchanged and is based on 60x our 2016 EPS estimate of $4.96 discounted to present at 11%.

Related articles
Leave a Comment
by jackbassteam on May 24, 2013  •  Permalink
Posted in Networking, Social Media
Tagged , , , , , , ,

Posted by jackbassteam on May 24, 2013

http://amp2012.com/2013/05/24/linkedin-buy-target-200/

Workday

Image representing Workday as depicted in Crun...

Image via CrunchBase

WDAY : NYSE : US$65.75
BUY 
Target: US$75.00

COMPANY DESCRIPTION:
Workday provides enterprise-scale, cloud applications that deliver the core functions for global customers to manage the human capital and financial resources of an organization. Solutions include: HCM, Financial Management, Payroll, Time Tracking, Procurement, Employee Expense Management, etc. Workday was founded by the former founders of PeopleSoft in 2005 and is headquartered in Pleasanton, CA.

Investment recommendation


Workday delivered another of what we expect to be several more years of quarterly beat and raises. In a world of near-zero interest rates, a fast scaling firm like WDAY is likely to see its revenue growth exceed gradual multiple compression so that investors can logically expect 15%+ annual rates of return on the stock. Reiterate BUY and increasing price target to $75 (up $5).
Investment highlights
 Strong start to FY: another upside quarter. WDAY reported Q1/14 revenues of $91.6M, which was $4.1M ahead of our estimate and represented
normalized y-o-y growth of 75% (99% on the subscription line). Calculated billings of $107.3M were up 31% y-o-y and beat our estimate by $1.5M.
WDAY generated free cash flow of $15.3M (inclusive of several one-time gains), which was well ahead of our expectation for a material loss.
 Business highlights: large enterprises continue to select WDAY. During the quarter Bristol Myers and Levi Strauss chose WDAY for HR as well as
University of Miami for the full WDAY applications suite. Notable go-lives in the quarter included Johnson & Johnson, London Stock Exchange, and Cornell University. WDAY ended the quarter with more than 450 customers, of which 290 are live (up from 265 at the end of last quarter).
 Outlook: go-forward estimates inch nicely higher again. WDAY increased F2014 guidance by $5M and called for an operating loss that at mid-point was 250 bps better than last expected. We have increased our F2014 and F2015 revenue estimates by $8M and $10M, respectively, which are now 60% and 50% y-o-y revenue growth (and likely still a bit conservative

Related articles
Leave a Comment
by jackbassteam on May 24, 2013  •  Permalink
Posted in Cloud computing
Tagged , , , , , , ,

Posted by jackbassteam on May 24, 2013

http://amp2012.com/2013/05/24/workday/

ARM Holdings plc

The official logo for the ARM processor archit...

The official logo for the ARM processor architecture (Photo credit: Wikipedia)

ARMH : NASDAQ : US$47.24
ARM : LSE
BUY 
Target: US$56.00

COMPANY DESCRIPTION:
ARM is a leading semiconductor IP supplier to the diverse global semiconductor market. ARM’s revenues are driven through a licensing and royalty business model, with a majority of the royalty sales driven by the mobile market
including handsets, smartphones, and tablets. ARM also supplies semiconductor IP to the server, PC, and embedded markets and physical implementation libraries and IP to semiconductor foundries.
All amounts in US$ unless otherwise noted.

Investment recommendation:
From ARM’s analyst day yesterday in London where ARM management highlighted strong longterm market and royalty growth opportunities in both high- and low-tier smartphones.

We believe ARM is well positioned to benefit from quickly increasing emerging market feature phone to smartphone upgrades, ramping low-tier tablets, and high-tier smartphone platform refreshes that should drive royalty TAM growth and rate expansion. Further, with a growing number of ARM partners moving toward multi-core Cortex-A, big.LITTLE, and ARMv8 designs at leading edge process nodes, we anticipate strong license sales in the near to medium term will drive strong royalty revenue growth and both operating and earnings leverage long term. We reiterate our BUY rating and raise our price target to $56.
Investment highlights
 Our Q1/13 monthly handset sales surveys and recent March quarter results and June quarter guidance for ARM mobile chipset partners are consistent with ARM’s estimates for very strong growth of the low- and mid-tier smartphone markets and also resilient growth of the high-tier market driven flagship launches and 4G/LTE upgrades.
 At its analyst day, ARM shared its target of 15-25% smartphone royalty sales CAGR through 2017 and anticipates smartphone unit CAGR of 20% for the industry during the same period. In fact, this estimate includes growth in both the high- and lower-tier smartphone markets, and we believe ARM will generate significant royalty revenue growth from both tiers driven by a royalty rate expansion multiplier in the slower-growing high-tier market and upgrades
from lower royalty feature phones in lower tiers.
 Due to increased royalty estimates from lower tier smartphones and tablets, we are increasing our 2013 earnings/ADS estimate from $1.01 to $1.02 and our 2014 estimate from $1.31 to $1.35.

Valuation:

Our $56 price target (from $52) is based on shares trading at
roughly 42x our 2014 normalized earnings/ADS estimate.

Related articles
Leave a Comment
by jackbassteam on May 23, 2013  •  Permalink
Posted in Smartphones, Tablets, Tech stocks, Telecommunications
Tagged , , , , , , ,

Posted by jackbassteam on May 23, 2013

http://amp2012.com/2013/05/23/arm-holdings-plc/

AcelRx Pharmaceuticals

Image representing AcelRx Pharmaceuticals as d...

Image via CrunchBase

ACRX : NASDAQ : US$6.40
BUY 
Target: US$11.00 

COMPANY DESCRIPTION:
AcelRx Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. AcelRx’s lead product, ARX-01, is designed to provide patient-controlled analgesia (PCA) and overcome the issues currently
encountered with IV PCAs.
All amounts in US$ unless otherwise noted.

RAISE TARGET TO $11 ON POSITIVE
PHASE 3 DATA; REITERATE BUY
AcelRx reported  that it has achieved its primary endpoint (SPID-48) for its placebo-controlled Phase 3 study in major orthopedic surgery (knee or hip replacement) for its sublingual Sufentanil NanoTab PCA System.
This is the third (of a total of three) Phase 3 studies the company has completed, and NDA submission remains on track for Q3 2013. We continue to see an attractive market opportunity for ARX-01 in the hospital setting, with un-risk adjusted peak sales of $577 million in 2022.
Post positive data we have reviewed our model and are lowering our risk adjustment and WACC rate given the further de-risked outlook. We
reiterate our BUY rating and raise our price target to $11.
 EPS and ARX-01 NPV move higher on lower risk-adjustment. Our EPS (risk-adjusted) estimates move to ($0.68), ($0.62), $0.11, $0.77, and $1.18 on a 70% risk-adjustment (from 60%), which reflects a derisked outlook post data. Our ARX-01 NPV also moves higher on a lower WACC rate (20% from 26%), which delivers a ~$10.77 value.
Our underlying ARX-01 assumptions remain unchanged, which still drives peak sales of $577 million (un-risk adjusted) in 2022.
 Study achieves primary endpoint with mild to moderate adverse events. The study enrolled 426 adult patients at 34 US sites and showed a significantly greater SPID-48 versus placebo-treated patients (+76.1 vs -11.5, p<0.001) while also hitting secondary endpoints. Adverse events were mild to moderate and were similar in both placebo and treatment groups for majority of AEs.
 Reiterate BUY, raising target to $11. Our $11 target is based on both our ARX-01 NPV (un-risk adjusted) and a 17.0x P/E multiple applied to our risk-adjusted 2017 EPS discounted back.

Related articles
Leave a Comment
by jackbassteam on May 23, 2013  •  Permalink
Posted in Drug Stocks
Tagged , , , , , , ,

Posted by jackbassteam on May 23, 2013

http://amp2012.com/2013/05/23/acelrx-pharmaceuticals-2/

Conn’s, Inc.

English: The new Conn's logo

English: The new Conn’s logo (Photo credit: Wikipedia)

CONN : NASDAQ : US$47.37
BUY 
Target: US$63.00

Conn’s is a specialty retailer selling home appliances, consumer electronics, furniture and mattresses, home office, and lawn and garden  quipment. The company operates approximately 70 retail stores located primarily in Texas, as well as Louisiana, Oklahoma, Arizona, New Mexico and online. Conn’s provides its own proprietary inhouse credit program, including sales of related credit insurance products.

All amounts in US$ unles

Consumer & Retail — Specialty Retail
TOP-LINE GROWTH AND  EXPANDING RETAIL GROSS MARGINS REMAIN SIGNIFICANT ATALYSTS

Investment recommendation


We expect Conn’s to generate average annual revenue growth of 21% over the next five years supported by the company’s proprietary in-house financing program. We believe Conn’s square footage growth potential is the highest in the retail group, and increasing penetration of the higher-margin furniture and mattress business should continue to expand retail gross margin.
We are raising our FY14 retail gross margin forecast of by 120bps to 37.7% driven by our expectation for a faster mix shift to the furniture assortment. As a result, our FY14 EPS estimate moves $0.13 higher to $2.63, $0.14 above consensus and the highest estimate among sell-side analysts. We are raising our FY15 projection by $0.18 to $3.61, which is $0.43 ahead of consensus and the high estimate.

Investment highlights
 Store surveys indicate Conn’s is on track to grow square footage in line with our +31% FY14 estimate. Furniture penetration appears as high as 75% at new locations.
 We are raising our price target from $53 to $63 using an equal blend of the peer group multiple, our sum-of-the-parts valuation, and our DCF valuation model.

Related articles
Leave a Comment
by jackbassteam on May 22, 2013  •  Permalink
Posted in Retail Stores
Tagged , , , , , , ,

Posted by jackbassteam on May 22, 2013

http://amp2012.com/2013/05/22/conns-inc/

Ecolab

ECL : NYSE : US$88.08
BUY 
Target: US$100.00

COMPANY DESCRIPTION:
Based in St. Paul, Minnesota, Ecolab is a leading international provider of advanced technologies and services helping to optimize the use of resources such as water, energy, food and the environment

PRICE TARGET TO $100
Investment recommendation

We find Ecolab very well positioned to benefit from the convergence ofpopulation growth, resource volatility and rapid industrialization across
the world. The company’s recurring services model drives high visibility (even in an uncertain macro environment), while the energy platform
looks positioned for strong earnings growth post Champion. Maintain BUY.
Investment highlights
 We recently attended the National Restaurant Association (NRA) show in Chicago, including an impressive booth tour with CEO Doug Baker and presentation from Global F&B President Jill Wyant.
 In short, from food and beverage “factories” all the way to the food court and fine dining, Ecolab offers a comprehensive portfolio of solutions to ensure food safety/regulatory compliance and optimize operational efficiency, among other benefits (environmental sustainability, etc.). Full details below.
 The commitment to innovation is clear (including recent product introductions and healthy pipeline), while the outlook for Nalco cross-selling stays encouraging (3D TRASAR for clean-in-place, etc.).
Valuation
Our 12 month target of $100 (from $93) equates to an EV/EBITDA multiple of ~11.8x from (~11.2x) our 2014 estimate.
Risks
Global macroeconomic conditions, seasonal sales patterns, commodity
costs, competition, regulatory dynamics and M&A integration

Related articles
Leave a Comment
by jackbassteam on May 22, 2013  •  Permalink
Posted in Food
Tagged , , , , , , ,

Posted by jackbassteam on May 22, 2013

http://amp2012.com/2013/05/22/ecolab/

21Vianet Group

VNET : NASDAQ : US$9.46
BUY 
Target: US$15.00

COMPANY DESCRIPTION:
The largest carrier-neutral Internet data center service provider in China, 21Vianet hosts customers’ servers and networking equipment and provide interconnectivity services. The company also provides managed network services through its data transmission network

Investment recommendation


We maintain our BUY rating and $15.00 price target following 21Vianet’s Q1/13 report that demonstrates its ability to sustain its growth
momentum and overcome some of the temporary disruptions from capacity upgrades. We believe that the incremental investments in new
data centers, network capacity and cloud computing, while temporarily dampening margins, will result in higher growth and profitability in 2H13
and beyond. Priced at 5.7x 2014E adj. EBITDA, the shares of VNET offers compelling risk/reward for investors, in our view.
Investment highlights
 Solid revenue, slightly soft margin on investments – Q1/13 revenue came in stronger than expected (RMB 435.7M vs. 433.3M CGe) with
slightly lighter-than-expected EBITDA (RMB 80.1M vs. 82M). We note that higher-than-expected operating costs were attributed to higher
bandwidth costs with greater network capacity and continued investments ahead of revenue contribution from cloud computing.
 Signs of hope from Q2/13 outlook – Although Q2/13 guidance is not as strong as we had hoped, it nonetheless confirms our view that the
disruption from recent capacity upgrade is now behind and that the company’s growth momentum is picking up again. Following two quarters of decelerating growth, we believe the change in trajectory  marks an important inflection point for investors.
 shift to higher MRR cabinets in large cities and revenue contribution from Microsoft cloud will likely improve both revenue and margins

Leave a Comment
by jackbassteam on May 21, 2013  •  Permalink
Posted in Tech stocks, Telecommunications
Tagged , , , , , , ,

Posted by jackbassteam on May 21, 2013

http://amp2012.com/2013/05/21/21vianet-group-2/

Bombardier

English: Bombardier CSeries mockup Italiano: M...

English: Bombardier CSeries mockup Italiano: Modello dimostrativo del Bombardier CSeries (Photo credit: Wikipedia)

BBD.B : TSX : $4.64

Shares of Bombardier were higher after press reports indicated that EasyJet is on the verge of a large new order that may include BBD’s CSeries commercial jets. As reported by LesEchos, the British company, which reported a significant improvement in half-yearly results, is preparing a new giant order of more than 100 aircraft in the coming weeks, which would incorporate Airbus A320 or Boeing 737, as well as Bombardier CSeries. “Our future order will focus on Airbus or Boeing, but also on Bombardier,” said Carolyn McCall, Executive Director, at the presentation of the half-year results.

Recently, BBD reported its Q1/13 report where the company reiterated its 2013 and 2014 guidance.

Key points include: BBD expects 190 business jet deliveries, up from 179 in 2012, and 55 regional airliners, an increase from 50 units in 2012.
BBD’s Q1/13 business jet orders of only 27 units were on the low side.

Canaccord s Analyst David Tyerman think this is temporary. Management reiterated that it is cautiously optimistic about order prospects
given the company’s pipeline, especially in larger aircraft types. Regional airliner orders were very weak in Q1/13, with no regional jets ordered and only four turboprop orders secured. However, as with business jets, these orders are lumpy.

BBD continues to believe it has a good shot at larger U.S. airline orders as those airlines up-gauge smaller regional jets. In addition, the company is positioned to capture further orders from Garuda from option conversion and Russia, China and Africa hold some promise.

Related articles
Leave a Comment
by jackbassteam on May 21, 2013  •  Permalink
Posted in Aircraft
Tagged , , , , , , ,

Posted by jackbassteam on May 21, 2013

http://amp2012.com/2013/05/21/bombardier/

« Older Posts
Follow

Get every new post delivered to your Inbox.

Join 1,179 other followers